2020 - 2022年美国新冠疫情期间门诊抗生素处方情况的最新报告
Update on outpatient antibiotic prescribing during the COVID-19 pandemic: United States, 2020-2022.
作者信息
Bizune Destani, Gouin Katryna, Powell Lauren, Hersh Adam L, Hicks Lauri A, Kabbani Sarah
机构信息
Medical Product Safety Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Department of Pediatrics, Division of Infectious Diseases, University of Utah, Salt Lake City, UT, USA.
出版信息
Antimicrob Steward Healthc Epidemiol. 2024 Oct 31;4(1):e193. doi: 10.1017/ash.2024.398. eCollection 2024.
We updated a descriptive analysis of national outpatient antibiotic prescribing during the COVID-19 pandemic. Prescribing volume was lower during 2020 and January-June in 2021 and 2022 compared to corresponding baseline months in 2019. Prescribing approached or exceeded baseline during July-December of 2021 and 2022 for all antibiotics, especially for azithromycin.
我们更新了对新冠疫情期间全国门诊抗生素处方的描述性分析。与2019年相应的基线月份相比，2020年以及2021年和2022年1月至6月的处方量较低。2021年和2022年7月至12月，所有抗生素的处方量接近或超过基线，尤其是阿奇霉素。
Zotero 插件